calu-3（人肺癌細(xì)胞(腺癌)）
CBP60086
詢(xún) 價(jià)
索取STR
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫(kù)
| I. General information | |
| Synonyms: | calu-3 |
| Species: | Homo sapiens, human |
| Tissue: | lung adenocarcinoma; derived from metastatic site: pleural effusion |
| Disease: | adenocarcinoma |
| Gender: | male,25 years,Caucasian,The patient had received prior therapy with cytoxan, bleomycin and adriamycin. |
| Morphology: | epithelial |
| Growth Mode: | adherent |
| DNA Profile: | Amelogenin: X CSF1PO: 11,12 D13S317: 12 D16S539: 12,14 D5S818: 11 D7S820: 10,11 THO1: 6,9.3 TPOX: 8 vWA: 16,17 Our Cell Line Authentication Service |
| Culture Medium: |
MEM+10%FBS+1% Non Essential Amino Acids (NEAA) + 1mM Sodium Pyruvate (NaP) calu-3完全培養(yǎng)基，# CBP60086M |
| Cryopreservation medium: | 90%FBS+10%DMSO |
| Antigen Expression: | Antigen expression: Blood Type A; Rh+ |
| Genes Expressed: | Blood Type A; Rh+ |
| Tumor Formation: | Yes, forms well differentiated grade I adenocarcinoma in nude mice |
| Comments: | The patient had received prior therapy with cytoxan, bleomycin and adriamycin.For more information, please contact us (4008-750-250). |
